Corbus Pharmaceuticals Holdings, Inc. Skyrocketed
Fri, Jan 26, 2024 at 07:21 PM
Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ) shot up at $29.49, a gain of 249.4%. On Fri, Jan 26, 2024, CRBP:NASDAQ touched a New 2-Week High of $29.49. The stock got featured on our News Catalysts scanner on Fri, Jan 26, 2024 at 10:50 AM in the 'BIOTECH' category. From Fri, Jan 12, 2024, the stock recorded 88.89% Up Days and 70.00% Green Days
The stock spiked on Fri, Jan 26, 2024 at $39.96 with a volume of 32M+.
About Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ)
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.
Top 10 Gainers:
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 249.41%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 83.01%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 80%
- China Xiangtai Food Co. Ltd. (BTOG:NASDAQ), 64.21%
- IM Cannabis Corp. (IMCC:NASDAQ), 59.5%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 57.94%
- Aclarion Inc. (ACON:NASDAQ), 52.28%
- Selina Hospitality PLC (SLNA:NASDAQ), 40.74%
- SpringBig Holdings Inc. (SBIG:NASDAQ), 38.79%
- Baijiayun Group Ltd Ord Cl A (RTC:NASDAQ), 37.53%